Labcorp Holdings Inc. (NYSE:LH) Q4 2025 Earnings Call Transcript February 17, 2026 Labcorp Holdings Inc. misses on earnings expectations. Reported EPS is $1.98 EPS, expectations were $3.95. Operator: ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to ...

Labcorp posted higher fourth-quarter profit boosted by growth in its diagnostic laboratories business. The company reported net income of $164.7 million, or $1.98 a share, up from $143.4 million, or ...

Labcorp Holdings Inc. , a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter and full year ended December 31, 2025, and provided 2026 ...

The latest nutrition guidelines urge Americans to avoid highly processed food. But when it comes to carbs, many people don't ...

In February 2026, Labcorp announced nationwide availability of the Elecsys pTau-181 blood test, the first FDA-cleared primary-care tool to aid in ruling out Alzheimer’s disease by identifying ...

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

BURLINGTON, N.C., Feb. 11, 2026 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today the nationwide availability of the Elecsys® ...

LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...

Labcorp Holdings said it would soon offer a blood test for diagnosing Alzheimer's disease in primary-care settings. The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test ...